T cells take aim in AML: targeting IDH2

Blood. 2024 Apr 25;143(17):1681-1682. doi: 10.1182/blood.2024023892.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Isocitrate Dehydrogenase* / genetics
  • Isocitrate Dehydrogenase* / metabolism
  • Leukemia, Myeloid, Acute* / genetics
  • Leukemia, Myeloid, Acute* / pathology
  • Mutation
  • T-Lymphocytes / metabolism

Substances

  • IDH2 protein, human
  • Isocitrate Dehydrogenase